A DYNC1H1 mutation in autosomal dominant spinal muscular atrophy shows the potential of pharmacological inhibition of histone deacetylase 6 as a treatment for disease associated cellular phenotypes

Green, R., Simoes, F. A., Reyes-Aldasoro, C. C., Rossor, A. M., Scoto, M., Barri, M., Greensmith, L., Muntoni, F., Reilly, M. M. & Hafezparast, M. (2016). A DYNC1H1 mutation in autosomal dominant spinal muscular atrophy shows the potential of pharmacological inhibition of histone deacetylase 6 as a treatment for disease associated cellular phenotypes. Journal Of The Peripheral Nervous System, 21(3), pp. 261-262. doi: 10.1111/jns.12181

[img] Text - Accepted Version
Restricted to Repository staff only until 4 September 2017.

Download (56kB) | Request a copy

Item Type: Article
Additional Information: This is the peer reviewed version of the following article: Green, R., Simoes, F. A., Reyes-Aldasoro, C. C., Rossor, A. M., Scoto, M., Barri, M., Greensmith, L., Muntoni, F., Reilly, M. M. & Hafezparast, M. (2016). A DYNC1H1 mutation in autosomal dominant spinal muscular atrophy shows the potential of pharmacological inhibition of histone deacetylase 6 as a treatment for disease associated cellular phenotypes. Journal Of The Peripheral Nervous System, 21(3), pp. 261-262., which is published in final form at http://dx.doi.org/10.1111/jns.12181. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
Subjects: R Medicine > RC Internal medicine
T Technology > TK Electrical engineering. Electronics Nuclear engineering
Divisions: School of Engineering & Mathematical Sciences > Engineering
URI: http://openaccess.city.ac.uk/id/eprint/15763

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics